Tregeutix

Tregeutix is a company that specializes in antigen-specific immunotherapy. It studies the way how microbiota derived antigen cross-reactivity maintains full and complete repertoire of Foxp3+ regulatory T cells (Tregs). The company develops SPIRAL (Specific ImmunoRegulatory Algorithm), a discovery framework that predicts each Treg, regardless of its perceived antigen specificity.